Failure-free survival after initial systemic treatment of chronic graft-versus-host disease

This study was designed to characterize failure-free survival (FFS) as a novel end point for clinical trials of chronic graft-versus-host disease (GVHD). The study cohort included 400 consecutive patients who received initial systemic treatment of chronic GVHD at our center. FFS was defined by the a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Inamoto, Yoshihiro, Flowers, Mary E. D., Sandmaier, Brenda M., Aki, Sahika Z., Carpenter, Paul A., Lee, Stephanie J., Storer, Barry E., Martin, Paul J.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2014
Materias:
Transplantation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4141518/
https://ncbi.nlm.nih.gov/pubmed/24876566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-03-563544
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares